Angela Strand

Angela is an experienced executive, advisor and serial entrepreneur with a 25-year track record of founding and building disruptive, technology-based products and companies across a range of diverse global industries, including e-mobiilty, biotech/medtech, consumer health, technology, software and transportation & logistics. She is a named inventor on 7 issued patents. She is presently the founder and managing director of Strand Strategy, a boutique technology advisory firm and founder and CEO of Cliffdive Records. Formerly, Angela served in leadership, director and executive roles for multiple public companies and growth-stage companies that had subsequent successful exits including Aerogen (acquired by Nektar Therapeutics, NASDAQ:NKTR), Novacept (acquired by Cytyc, NASDAQ: CYTC, now NASDAQ: HOLX) and FemRx (acquired by J&J). Strand previously worked for Baxter Healthcare, Federal Express and IBM. She holds a B.S. in communications and an M.B.A. in marketing from the University of Tennessee.